Novalis Biotech is an early-stage venture capital investor focusing on enabling technologies in the life sciences. They aim to support innovative healthcare concepts from the incorporation stage, emphasizing capital-light platform technologies and close customer interaction early in the company's lifecycle. The firm focuses on funding, professional/academic connections, and business strategy to create value for all stakeholders, supporting early-stage startups from pre-seed to Series A stages.
Preferred startup development maturity for initial funding deployment.
innovative research and manufacturing tools, bioinformatics, genomics, diagnostics, digital health
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...